Key Points

• In 2023, vaccination coverage among infants subject to the mandatory vaccination requirements in effect since 2018 is high for vaccinations against diphtheria, tetanus, polio, pertussis, Haemophilus influenzae type b, hepatitis B, pneumococcus, and meningococcus C; however, coverage remains insufficient for the measles, mumps, and rubella (MMR) vaccine, with coverage of 85.2% for the second dose of this vaccine. Given the current circulation of the measles virus, only a two-dose vaccination coverage of at least 95% is likely to interrupt transmission of the virus.

• Vaccination coverage against meningococcal B infections is showing a marked increase, with three-quarters of infants born in 2023 having received at least one dose of the meningococcal B vaccine—an increase of nearly 24 percentage points compared to 2022, the year this vaccine was introduced into the immunization schedule.

• About 30% of infants born in 2023 received at least one dose of the rotavirus vaccine.

• Although vaccination coverage against meningococcal C infections has increased by 4.7 percentage points among adolescents compared to 2022, catch-up vaccination remains very insufficient among young people aged 15 to 19, with a vaccination coverage rate of 42.9% in 2023.

• Vaccination coverage against human papillomavirus (HPV) rose sharply in 2023, with 59.4% of girls and 27.8% of boys aged 15 having started their HPV vaccination series—an increase of nearly 8 percentage points among girls and nearly 15 percentage points among boys compared to 2022. However, HPV coverage remains far from the 80% target set in the 10-year cancer control strategy for 2030.

• At the end of the first phase of the HPV vaccination campaign in middle school, as of December 31, 2023, it is estimated that approximately 61% of girls and 48% of boys aged 12 (born in 2011, mostly enrolled in 7th grade) have received at least one dose of the HPV vaccine. These estimates take into account vaccinations administered in middle schools and in the community. An increase of 21 percentage points among girls and 22 percentage points among boys in vaccination coverage was observed between the start and end of the first phase of the campaign, although it is not yet possible to specify the gain directly attributable to the campaign at this stage.

• Vaccination coverage against influenza and COVID-19 remains insufficient among at-risk individuals. During the 2023-24 season, influenza vaccination coverage was down by 6 percentage points compared to the 2022-23 season (49.7% vs. 55.9%). This coverage remained stable among those aged 75 and older, but declined among those aged 65–74 and among those under 65 at risk. COVID-19 vaccination coverage was 32.5% among those aged 65 and older. Initial estimates of shingles vaccination indicate that very few people aged 65–74 are vaccinated against shingles (1%).

• Regional disparities are still observed within the region, with lower vaccination coverage in rural departments.